Aptadir Therapeutics raises $45m seed to advance RNA inhibitors
Milan-based biotech Aptadir Therapeutics said it has raised a $45m seed round, one of the largest seed investments by an Italian health startup and among...
This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info